Lee found that vitamin D links with a gene
known as G6PD, increasing its activity and
the production of an enzyme called
glucose-6-phosphate dehydrogenase. Increased
activity of the enzyme clears cells of ROS,
the molecules that can damage and injure
cells.
“If you reduce DNA damage, you reduce the risk
of cancer or aging,” Lee said.
“Our study adds one more beneficial effect of
taking a vitamin D supplement. Taking a
supplement is especially important for
senior citizens and others who might have
less circulation of vitamin D, and for
people who live and work areas where there
is less sunshine.”
Large amounts of vitamin D should not be taken
without medical supervision, she said.
The G6PD pathway is one of the mechanisms
vitamin D uses, Lee said. The researchers
did not find any similar activity in
prostate cancer cells.
“Vitamin D does not protect cancer cells from
injury or damage, which is good,” Lee said.
###
The current research was supported by a grant
from the U.S. Department of Defense.
In addition to Lee, authors of the
International Journal of Cancer article
include Bo-Ying Bao of China Medical
University, Taichung, Taiwan, and Huei-Ju
Ting and Jong-Wei Hsu of the Medical Center.
In the journal Carcinogenesis in 2006, Lee
reported that vitamin D can inhibit the
spread of prostate cancer by limiting the
ability of cancer cells to invade healthy
cells by reducing the activity of two
specific enzymes, proteases called matrix
metalloproteinase and cathepsin.
The research was conducted in test tubes using
human prostate cancer cell lines. That
finding indicated that vitamin D could
provide beneficial treatment to prostate
cancer patients with high levels of the
enzymes.